클래시스

214150KOSDAQView the 의료·정밀기기 sectorTheme Bio & healthcare

26,500KRWMarket close of 10/27 (Tue)

Down -2.57%-700KRWMarket close of 10/27 (Tue)

Preliminary value — replaced once official KRX data for the same date is publishedClose of 10/28 (Wed)27,000KRWUp +1.89%

Preliminary · replaced once official KRX data for the same date is published

Open
27,450
High
28,050
Low
26,400
Day range
Day range low 26,400 high 28,050, open 27,450, close 26,500, previous close 27,200
Volume
19×10K shares
5.1B KRW 1.04× the 20-session average

Market close of 10/27 (Tue)

Where it sits in the 1-year range

1-year close range 26,500 to 75,600 won, 0% up from the low

0% of the way up from the lowest close in 1 year (252 sessions) · -64.9% from the high

Loading

Free · no sign-inSource from 2021-05-17

Data dateMost recent closing data10/27 (Tue)
Market close data of 2026-10-27

Points to check

  • Recent filingsnot verifiedCould not read filing data, so not verified
  • Foreign & institutionalnot verifiedFlow is dated 2026-10-28 and price is dated 2026-10-27; flow is not combined into this check.
  • Daily moveusual range-2.57%-2.57%, 1.1× the usual (20-session average ±2.39%)
    That day -2.57% · usual ±2.39% · large-move threshold ±4.8%

The other 2 are within the usual range

  • Trading value1.0×usual range
  • EarningsOperating income, 8 quartersOperating income, 8 quarters
See the full check report
Loading

Same sector · 의료·정밀기기

Up +2.12%

· 64 of 101 stocks up, preferred shares excluded · trading value 174.2B KRW

Same sector · top by trading value
Stock20DChangeTrading value
디아이Close over the last 20 sessions +2.9%Up +4.71%19.5B KRW
티에스이Close over the last 20 sessions -10.0%Up +7.88%19.1B KRW
노을Close over the last 20 sessions +29.9%Down -7.14%15.8B KRW
씨어스Close over the last 20 sessions +5.0%Down -5.57%15.2B KRW
빅텍Close over the last 20 sessions +5.5%Down -0.16%14.6B KRW

Schedule

  • Q3 report due · 11/16 (Mon) · in 18 days
  • Next data 10/29 (Thu) after 08:50

Related news

All news
Loading

For information only, not a solicitation to invest. Investment decisions and their results are your own responsibility.